Join us at the NASS Annual Spine Meeting in Boston for an onsite Skills Lab and a keynote dinner at the New England Aquarium.
Wednesday, Sept. 29th at 5:00, 6:00, or 7:00 pm,
Exhibit Hall - Lab L3071
Hands-on sessions demonstrated and proctored by Prof. Dr. Claudius Thomé, K. Brandon Strenge, MD, and Pierce Nunley, MD.
Beverages and appetizers will be provided.
Thursday, Sept. 30th at 6:30 pm
1 Central Wharf, Boston, MA 02110 (transportation provided)
Professor Claudius Thomé and Michael Musacchio, MD will present their clinical and practical experience from the Barricaid RCT and US post approval study:
• Pivotal trial results and extended follow-up
• US patient results
• Barricaid’s effect on practice reimbursement
• Patient selection and surgical best practices
• Only FDA approved device designed to prevent disc reherniation and reoperation
Beverages, heavy appetizers and shuttle service will be provided.
Prof. Dr. Claudius Thomé
Prof. Dr. Thomé has served as Full Professor and Chairman of the Dept. of Neurosurgery, Medical University Innsbruck, Austria since 2010.
He is the principal investigator of Barricaid's 554-patient RCT, publishing 2-year findings in The Spine Journal in 2018.
Michael Musacchio, MD
Dr. Musacchio is a neurosurgeon specializing in minimally invasive spine surgery techniques. He has more than 19 years’ experience in neurological surgery.
Dr. Musacchio is currently a clinical investigator in the Barricaid U.S. Post-Approval Study.
K. Brandon Strenge, MD
Dr. Brandon Strenge is one of the founding members
of The Orthopaedic Institute of Western Kentucky. He is a fellowship-trained orthopedic spine surgeon specializing in minimally invasive spinal surgery and motion-preserving procedures to treat both cervical and lumbar spine disorders.
Pierce Nunley, MD
Dr. Nunley is the founder and Medical Director of the Spine Institute of Louisiana and has an academic appointment as Associate Professor at LSU Health.
He is currently a clinical investigator in the Barricaid U.S. Post-Approval Study.
Check out Barricaid’s recent features in Becker’s Spine Review and Stanford Medicine News.